NORTH CHICAGO, Ill., Feb. 15, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend and also authorized a share repurchase program of up to $1.5 billion of the Company's outstanding common stock.

NORTH CHICAGO, Ill., Jan. 30, 2013 /PRNewswire/ -- AbbVie today confirmed it delivered strong sales growth with its marketed pharmaceutical products in 2012.  The proprietary pharmaceutical segment of Abbott, representing the majority of AbbVie's revenue, grew more than 8 percent globally on an operational basis, excluding a nearly 3 percent negative impact from foreign exchange.   

NORTH CHICAGO, Ill., Jan. 21, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, has been named to the S&P 500 Dividend Aristocrat Index for 2013.

NORTH CHICAGO, Ill., Jan. 4, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, today declared the Company's first quarterly cash dividend of $0.40 per share. 

NEW YORK, Jan. 2, 2013 /PRNewswire/ -- AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.